On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.

The Food and Drug Administration’s (FDA) recent authorization of FluMist for at-home administration marks the beginning of a new chapter in vaccine access and delivery. Before now, self ...

The FDA has approved the at-home use of FluMist, a nasal spray flu vaccine, available in fall 2025. Effective for healthy people aged 2 to 49, it offers a needle-free option but isn't suitable for ...

In late September, 2024, the FDA approved the FluMist for self or caregiver administration, but this option isn’t expected to be available until the next flu season. If you decide to go with the ...

Gentle nasal spray vaccines against COVID, the flu and RSV are coming. They may work better than shots in the arm ...

One of the new developments is a nasal spray flu vaccine, aptly called FluMist, that people can self-administer. The spray was approved by the FDA just last month. “You can get a prescription ...

Q2 2025 Earnings Conference Call October 31, 2024 2:30 AM ET. Company Participants. Hiroyuki Okuzawa - Representative Director, Presi ...

FluMist is an efficacious and safely tolerated intranasal influenza vaccine. FluMist has gained approval from the FDA for self-administration by patients aged 18-49. FluMist is the first influenza ...